ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B6SPMN59
Stock Name / FundiShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerSPMV(USD) LSE
ETF TickerIBCK(EUR) F
ETF TickerMVUS.MI(EUR) CXE
ETF TickerSPLVz(CHF) CXE
ETF TickerSPMV.LS(USD) CXE
ETF TickerMVUS(EUR) ETF Plus
ETF TickerSPMV(EUR) ETF Plus
ETF TickerSPMV.L(GBP) LSE

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-12-03 (Wednesday)8,155USD 5,901,529REGN holding decreased by -149481USD 5,901,5290USD -149,481 USD 723.67 USD 742
2025-12-02 (Tuesday)8,155USD 6,051,010REGN holding decreased by -66137USD 6,051,0100USD -66,137 USD 742 USD 750.11
2025-12-01 (Monday)8,155USD 6,117,147REGN holding decreased by -245302USD 6,117,1470USD -245,302 USD 750.11 USD 780.19
2025-11-28 (Friday)8,155USD 6,362,449REGN holding decreased by -36046USD 6,362,4490USD -36,046 USD 780.19 USD 784.61
2025-11-27 (Thursday)8,155USD 6,398,495USD 6,398,4950USD 0 USD 784.61 USD 784.61
2025-11-26 (Wednesday)8,155REGN holding increased by 209USD 6,398,495REGN holding increased by 142450USD 6,398,495209USD 142,450 USD 784.61 USD 787.32
2025-11-25 (Tuesday)7,946REGN holding increased by 44USD 6,256,045REGN holding increased by 239067USD 6,256,04544USD 239,067 USD 787.32 USD 761.45
2025-11-24 (Monday)7,902REGN holding increased by 33USD 6,016,978REGN holding increased by 68801USD 6,016,97833USD 68,801 USD 761.45 USD 755.9
2025-11-21 (Friday)7,869REGN holding increased by 22USD 5,948,177REGN holding increased by 164938USD 5,948,17722USD 164,938 USD 755.9 USD 737
2025-11-20 (Thursday)7,847REGN holding increased by 44USD 5,783,239REGN holding increased by 299681USD 5,783,23944USD 299,681 USD 737 USD 702.75
2025-11-19 (Wednesday)7,803USD 5,483,558REGN holding decreased by -176270USD 5,483,5580USD -176,270 USD 702.75 USD 725.34
2025-11-18 (Tuesday)7,803USD 5,659,828REGN holding increased by 164097USD 5,659,8280USD 164,097 USD 725.34 USD 704.31
2025-11-17 (Monday)7,803USD 5,495,731REGN holding increased by 84350USD 5,495,7310USD 84,350 USD 704.31 USD 693.5
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00B6SPMN59

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-26BUY209790.980777.000 778.398USD 162,685 643.95
2025-11-26BUY209790.980777.000 778.398USD 162,685 643.95
2025-11-25BUY44790.570760.700 763.687USD 33,602 643.25
2025-11-24BUY33773.130756.640 758.289USD 25,024 642.66
2025-11-21BUY22 755.900* 642.10
2025-11-20BUY44 737.000* 641.62
2025-11-11BUY154676.330651.410 653.902USD 100,701 639.63
2025-11-10SELL-154665.990653.190 654.470USD -100,788 639.55 Loss of -2,298 on sale
2025-11-07SELL-132 657.530* 639.45 Profit of 84,408 on sale
2025-11-06BUY132657.000641.260 642.834USD 84,854 639.41
2025-11-04SELL-11646.221625.140 627.248USD -6,900 639.45 Profit of 134 on sale
2025-10-27BUY44585.310586.150 586.066USD 25,787 639.43
2025-10-22SELL-22584.740588.710 588.313USD -12,943 640.43 Profit of 1,147 on sale
2025-10-20BUY66576.770582.650 582.062USD 38,416 641.14
2025-10-15SELL-44576.420584.870 584.025USD -25,697 642.28 Profit of 2,563 on sale
2025-10-14BUY22572.600576.180 575.822USD 12,668 642.69
2025-10-03BUY22600.000618.010 616.209USD 13,557 642.94
2025-09-30BUY11562.270574.040 572.863USD 6,301 643.92
2025-09-25BUY11555.510579.000 576.651USD 6,343 645.44
2025-09-24SELL-9,971576.980577.980 577.880USD -5,762,041 645.85 Profit of 677,746 on sale
2025-09-16SELL-156575.060579.400 578.966USD -90,319 646.95 Profit of 10,606 on sale
2025-09-15BUY156572.590573.690 573.580USD 89,478 647.41
2025-09-12SELL-78560.000570.000 569.000USD -44,382 647.96 Profit of 6,159 on sale
2025-09-09SELL-56556.530563.570 562.866USD -31,520 649.64 Profit of 4,859 on sale
2025-07-30SELL-189554.580563.590 562.689USD -106,348 650.92 Profit of 16,676 on sale
2025-07-29BUY728558.150559.610 559.464USD 407,290 651.53
2025-07-16SELL-390547.930558.350 557.308USD -217,350 652.87 Profit of 37,271 on sale
2025-07-14SELL-52570.590575.130 574.676USD -29,883 654.12 Profit of 4,131 on sale
2025-07-11SELL-78567.740568.460 568.388USD -44,334 654.70 Profit of 6,733 on sale
2025-07-10SELL-26559.760566.370 565.709USD -14,708 655.34 Profit of 2,331 on sale
2025-07-09SELL-52552.580558.380 557.800USD -29,006 656.04 Profit of 5,109 on sale
2025-07-07BUY25538.110547.590 546.642USD 13,666 657.60
2025-07-03SELL-390547.360555.000 554.236USD -216,152 659.15 Profit of 40,915 on sale
2025-07-02SELL-50547.740551.500 551.124USD -27,556 659.93 Profit of 5,440 on sale
2025-06-23SELL-52511.920516.180 515.754USD -26,819 664.02 Profit of 7,710 on sale
2025-06-20SELL-26509.720521.310 520.151USD -13,524 665.14 Profit of 3,770 on sale
2025-06-18SELL-50513.580519.170 518.611USD -25,931 667.39 Profit of 7,439 on sale
2025-06-16SELL-312522.680538.200 536.648USD -167,434 669.67 Profit of 41,503 on sale
2025-06-13SELL-1,278529.240529.550 529.519USD -676,725 670.73 Profit of 180,473 on sale
2025-06-12SELL-1,151521.840525.220 524.882USD -604,139 671.87 Profit of 169,184 on sale
2025-06-11SELL-52518.600528.370 527.393USD -27,424 673.05 Profit of 7,574 on sale
2025-06-06BUY78493.220499.880 499.214USD 38,939 676.87
2025-06-05BUY104483.070491.770 490.900USD 51,054 678.41
2025-05-28SELL-78591.850606.000 604.585USD -47,158 686.07 Profit of 6,356 on sale
2025-05-27BUY78603.260608.170 607.679USD 47,399 686.76
2025-05-23SELL-234588.340591.640 591.310USD -138,367 688.44 Profit of 22,729 on sale
2025-05-22BUY52596.850605.500 604.635USD 31,441 689.23
2025-05-20BUY234614.790615.450 615.384USD 144,000 690.63
2025-05-16BUY99594.320595.190 595.103USD 58,915 692.33
2025-05-15BUY100584.990585.260 585.233USD 58,523 693.30
2025-05-14SELL-675571.360580.560 579.640USD -391,257 694.40 Profit of 77,466 on sale
2025-05-13BUY50574.160575.050 574.961USD 28,748 695.51
2025-05-12BUY125575.630577.990 577.754USD 72,219 696.62
2025-05-09SELL-100527.780552.840 550.334USD -55,033 698.20 Profit of 14,786 on sale
2025-05-08BUY75547.670552.570 552.080USD 41,406 699.62
2025-05-07SELL-125560.930568.130 567.410USD -70,926 700.94 Profit of 16,691 on sale
2025-04-30SELL-25598.760600.200 600.056USD -15,001 706.42 Profit of 2,659 on sale
2025-04-28SELL-150610.860614.830 614.433USD -92,165 708.80 Profit of 14,155 on sale
2025-04-23BUY25587.850603.770 602.178USD 15,054 712.34
2025-04-15BUY325557.910575.200 573.471USD 186,378 722.37
2025-04-14BUY50571.060574.720 574.354USD 28,718 724.09
2025-04-09SELL-150576.720580.730 580.329USD -87,049 729.92 Profit of 22,438 on sale
2025-04-08BUY75556.810586.030 583.108USD 43,733 731.98
2025-04-04BUY150573.450612.990 609.036USD 91,355 735.85
2025-04-02BUY73625.600628.000 627.760USD 45,826 737.21
2025-04-01SELL-225617.000641.240 638.816USD -143,734 738.72 Profit of 22,478 on sale
2025-03-31BUY1,184634.230640.720 640.071USD 757,844 740.04
2025-03-28BUY150637.360642.970 642.409USD 96,361 741.36
2025-03-27BUY294635.830643.430 642.670USD 188,945 742.73
2025-03-26BUY748640.140644.000 643.614USD 481,423 744.08
2025-03-25BUY513634.140662.570 659.727USD 338,440 745.54
2025-03-24SELL-75661.000667.460 666.814USD -50,011 746.68 Profit of 5,990 on sale
2025-03-21SELL-4,100658.480661.000 660.748USD -2,709,067 747.89 Profit of 357,295 on sale
2025-03-19BUY91672.360674.570 674.349USD 61,366 750.16
2025-03-17SELL-188678.420679.830 679.689USD -127,782 752.43 Profit of 13,676 on sale
2025-03-14SELL-94666.870686.980 684.969USD -64,387 753.69 Profit of 6,460 on sale
2025-03-13SELL-94680.610698.950 697.116USD -65,529 754.78 Profit of 5,421 on sale
2025-03-12SELL-188689.500712.460 710.164USD -133,511 755.77 Profit of 8,574 on sale
2025-03-07BUY282707.510729.750 727.526USD 205,162 757.31
2025-02-28BUY282698.740708.580 707.596USD 199,542 762.10
2025-02-26BUY376706.940721.410 719.963USD 270,706 764.11
2025-02-21BUY564700.330704.080 703.705USD 396,890 766.99
2025-02-18BUY188680.000689.950 688.955USD 129,524 771.68
2025-02-11BUY470665.460680.790 679.257USD 319,251 782.71
2025-02-07BUY188710.000731.420 729.278USD 137,104 786.47
2025-02-06BUY94722.070734.270 733.050USD 68,907 787.96
2025-02-05BUY282716.720729.250 727.997USD 205,295 789.66
2025-02-04BUY94697.050709.980 708.687USD 66,617 791.92
2025-01-31SELL-188672.980688.000 686.498USD -129,062 798.18 Profit of 20,995 on sale
2025-01-29SELL-188687.270697.570 696.540USD -130,950 804.28 Profit of 20,256 on sale
2024-12-10SELL-94778.500791.490 790.191USD -74,278 819.95 Profit of 2,798 on sale
2024-12-09SELL-94788.000800.990 799.691USD -75,171 820.98 Profit of 2,002 on sale
2024-11-27SELL-188754.870762.160 761.431USD -143,149 842.54 Profit of 15,249 on sale
2024-11-21SELL-376744.500757.560 756.254USD -284,352 862.81 Profit of 40,066 on sale
2024-11-20SELL-188743.350750.690 749.956USD -140,992 869.45 Profit of 22,465 on sale
2024-11-18SELL-188762.000762.700 762.630USD -143,374 883.97 Profit of 22,812 on sale
2024-11-12SELL-564821.000831.000 830.000USD -468,120 888.17 Profit of 32,806 on sale
2024-11-08SELL-1,504828.420830.730 830.499USD -1,249,070 892.43 Profit of 93,151 on sale
2024-11-07SELL-658824.480832.530 831.725USD -547,275 897.66 Profit of 43,386 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy